NCT00922831

Brief Summary

The purpose of this study is to look at multiple sclerosis patients process of awareness, learning, and judging status over a 3 year time period.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2008

Longer than P75 for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2008

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

June 16, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 17, 2009

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
Last Updated

April 12, 2018

Status Verified

April 1, 2018

Enrollment Period

5 years

First QC Date

June 16, 2009

Last Update Submit

April 10, 2018

Conditions

Multiple Sclerosis

Keywords

Cognition, Affective MS symptoms

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Neurology Care Clinic

You may qualify if:

  • Male/female subjects at least 18 years of age with a diagnosis of Clinically Definite Multiple Sclerosis (CDMS) or Clinically Isolated Syndrome (CIS)as confirmed by a neurologist.
  • Subjects must be able to give written informed consent and comply with the study protocol. Subjects must also be able to read, write and understand English.
  • Are capable of performing the requirements of the neuropsychological test battery.

You may not qualify if:

  • As judged by the investigator, any clinically significant, unstable or major concomitant disorder or medications.
  • In the opinion of the Investigator should not participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Hunter T Feaster, PsyD

    MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute

    PRINCIPAL INVESTIGATOR

  • Jared Bruce, PhD

    University of Missouri, Kansas City

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 16, 2009

First Posted

June 17, 2009

Study Start

August 1, 2008

Primary Completion

August 1, 2013

Study Completion

August 1, 2013

Last Updated

April 12, 2018

Record last verified: 2018-04